Author

Yijun Zhu

Sun Yat-sen UniversityORCID 0000-0003-2496-5395Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Boya Feng· 1 shared Clara BelzeriD· 1 shared Jo HandelsmaniD· 1 shared Justin J. J. van der HooftiD· 1 shared Liyuan Xiang· 1 shared Marc G. ChevretteiD· 1 shared Marnix H. MedemaiD· 1 shared Minhu CheniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Boya Feng

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsmSystemsPeer-reviewedDec 9, 2025

Using cross-species co-expression to predict metabolic interactions in microbiomes.

Robert A. Koetsier, Zachary L. Reitz, Clara Belzer…·Marnix H. Medema

This paper predicts microbial metabolic interactions using cross-species co-expression analysis of RNA-sequencing data from microbiome datasets.

3 citations

bulk RNA-seqstatistical model

𝕏 PostBluesky

MicrobiologybioRxivPreprintNov 25, 2025

3-Phenylpropionic acid, a microbiota-derived polyphenol metabolite linked to hippuric acid, ameliorates colitis as a colon-enriched PPAR-γ agonist

Liyuan Xiang, Wanrong Luo, Wenjie Zhang…·Yijun Zhu

This study identifies 3-phenylpropionic acid (3-PPA) as a colon-enriched PPAR-γ agonist derived from polyphenol metabolism, which ameliorates colitis in mice and highlights its potential as a microbiota-targeted therapeutic for Crohn's disease.

DOI 10.1101/2025.11.25.690607

mousemetagenomics

𝕏 PostBluesky